Beyond Exposure: Standardizing Buprenorphine Training in Pain Medicine Fellowship
Psychopharmacology Bulletin · 2026
DOI: 10.64719/pb.18525 ↗At a glance
Journal article in Psychopharmacology Bulletin, 2026. Written by Jamal Hasoon and 3 co-authors. Institution: Hasoon, Department of Anesthesiology, Critical Care, and Pain Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA. Major MEDLINE topics: Analgesics, Opioid, Buprenorphine, Chronic Pain, Fellowships and Scholarships. 26 references. The full text is freely available in PubMed Central.
Abstract (original language)
The American medical landscape is currently defined by a profound paradox. While the ongoing opioid crisis, characterized by a rise in synthetic illicit opioids continues to ravage communities, our primary pharmacological defense for both opioid use disorder (OUD) and chronic pain management remains underutilized in the very training programs designed to produce “experts” in the field. Pain medicine fellowship training frequently emphasizes the technical mastery of interventional procedures and non-opioid pharmacologic strategies. While these approaches are critically important, education in medication-assisted treatment (MAT), particularly the use of buprenorphine for OUD and complex chronic pain, often receives limited attention. The transition from the restrictive “X-waiver” era to the current regulatory environment was intended to expand and democratize access to buprenorphine treatment. However, legislative change alone cannot substitute for structured clinical education. Removing regulatory barriers does little to improve access if clinicians lack the knowledge, confidence, and training necessary to prescribe and manage these medications effectively. As the opioid crisis persists, it is critical that buprenorphine education be standardized as a core competency within pain medicine fellowship programs. Future pain specialists should be as comfortable initiating and managing buprenorphine therapy as they are performing advanced interventional procedures such as spinal cord stimulation. Strengthening training in this area will better equip pain physicians to address both chronic pain and opioid use disorder within an evolving and increasingly complex public health landscape.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Hasoon, Department of Anesthesiology, Critical Care, and Pain Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.
- Urits, Department of Pain Management, Southcoast Health, Wareham, MA, USA.
- Viswanath, Department of Anesthesiology, Critical Care, and Pain Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA; Mountain View Headache and Spine Institute, Phoenix, AZ, USA; Depart…
- Robinson, Department of Anesthesiology and Critical Care, Division of Pain Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Cite
APA
Hasoon, J., Urits, I., Viswanath, O., & Robinson, C. L. (2026). Beyond Exposure: Standardizing Buprenorphine Training in Pain Medicine Fellowship. Psychopharmacology Bulletin. https://doi.org/10.64719/pb.18525
Vancouver
Hasoon J, Urits I, Viswanath O, Robinson CL. Beyond Exposure: Standardizing Buprenorphine Training in Pain Medicine Fellowship. Psychopharmacology Bulletin. 2026. doi:10.64719/pb.18525
BibTeX
@article{Hasoon2026,
author = {Hasoon, Jamal and Urits, Ivan and Viswanath, Omar and Robinson, Christopher L},
title = {Beyond Exposure: Standardizing Buprenorphine Training in Pain Medicine Fellowship},
journal = {Psychopharmacology Bulletin},
year = {2026},
doi = {10.64719/pb.18525}
}
EUVIMED